NMR-based Metabolomic Analysis of Human Bladder Cancer
Bladder cancer (BC) is one of the most common cancers and has a high mortality rate. However, both metabolite variations and metabolic pathways related to the pathogenic process of BC remain to be addressed, such results might contribute to early detection of the disease. 1H nuclear magnetic resonan...
Saved in:
| Published in | Analytical Sciences Vol. 28; no. 5; pp. 451 - 456 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Singapore
The Japan Society for Analytical Chemistry
2012
Springer Nature Singapore Nature Publishing Group |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Bladder cancer (BC) is one of the most common cancers and has a high mortality rate. However, both metabolite variations and metabolic pathways related to the pathogenic process of BC remain to be addressed, such results might contribute to early detection of the disease. 1H nuclear magnetic resonance (NMR)-based metabolomics was applied to identify differences of serum metabolic profiles among BC, calculi patients and healthy subjects. Serum metabolic profiles of BC patients are distinctly different from those of calculi and healthy subjects. Compared with those from healthy subjects, serum samples from BC patients show decreased levels of isoleucine/leucine, tyrosine, lactate, glycine, citrate, as well as increased levels of lipids and glucose. The results reveal disturbed metabolic pathways of aromatic amino acids, glycolysis and citrate cycle, as well as lipogenesis metabolism in BC patients. Our work will be of potential benefit to understanding the pathogenic process of BC and will offer valuable information for noninvasive diagnosis of the disease. |
|---|---|
| AbstractList | Bladder cancer (BC) is one of the most common cancers and has a high mortality rate. However, both metabolite variations and metabolic pathways related to the pathogenic process of BC remain to be addressed, such results might contribute to early detection of the disease. (1)H nuclear magnetic resonance (NMR)-based metabolomics was applied to identify differences of serum metabolic profiles among BC, calculi patients and healthy subjects. Serum metabolic profiles of BC patients are distinctly different from those of calculi and healthy subjects. Compared with those from healthy subjects, serum samples from BC patients show decreased levels of isoleucine/leucine, tyrosine, lactate, glycine, citrate, as well as increased levels of lipids and glucose. The results reveal disturbed metabolic pathways of aromatic amino acids, glycolysis and citrate cycle, as well as lipogenesis metabolism in BC patients. Our work will be of potential benefit to understanding the pathogenic process of BC and will offer valuable information for noninvasive diagnosis of the disease. Bladder cancer (BC) is one of the most common cancers and has a high mortality rate. However, both metabolite variations and metabolic pathways related to the pathogenic process of BC remain to be addressed, such results might contribute to early detection of the disease. 1 H nuclear magnetic resonance (NMR)-based metabolomics was applied to identify differences of serum metabolic profiles among BC, calculi patients and healthy subjects. Serum metabolic profiles of BC patients are distinctly different from those of calculi and healthy subjects. Compared with those from healthy subjects, serum samples from BC patients show decreased levels of isoleucine/leucine, tyrosine, lactate, glycine, citrate, as well as increased levels of lipids and glucose. The results reveal disturbed metabolic pathways of aromatic amino acids, glycolysis and citrate cycle, as well as lipogenesis metabolism in BC patients. Our work will be of potential benefit to understanding the pathogenic process of BC and will offer valuable information for noninvasive diagnosis of the disease. Bladder cancer (BC) is one of the most common cancers and has a high mortality rate. However, both metabolite variations and metabolic pathways related to the pathogenic process of BC remain to be addressed, such results might contribute to early detection of the disease. (1)H nuclear magnetic resonance (NMR)-based metabolomics was applied to identify differences of serum metabolic profiles among BC, calculi patients and healthy subjects. Serum metabolic profiles of BC patients are distinctly different from those of calculi and healthy subjects. Compared with those from healthy subjects, serum samples from BC patients show decreased levels of isoleucine/leucine, tyrosine, lactate, glycine, citrate, as well as increased levels of lipids and glucose. The results reveal disturbed metabolic pathways of aromatic amino acids, glycolysis and citrate cycle, as well as lipogenesis metabolism in BC patients. Our work will be of potential benefit to understanding the pathogenic process of BC and will offer valuable information for noninvasive diagnosis of the disease.Bladder cancer (BC) is one of the most common cancers and has a high mortality rate. However, both metabolite variations and metabolic pathways related to the pathogenic process of BC remain to be addressed, such results might contribute to early detection of the disease. (1)H nuclear magnetic resonance (NMR)-based metabolomics was applied to identify differences of serum metabolic profiles among BC, calculi patients and healthy subjects. Serum metabolic profiles of BC patients are distinctly different from those of calculi and healthy subjects. Compared with those from healthy subjects, serum samples from BC patients show decreased levels of isoleucine/leucine, tyrosine, lactate, glycine, citrate, as well as increased levels of lipids and glucose. The results reveal disturbed metabolic pathways of aromatic amino acids, glycolysis and citrate cycle, as well as lipogenesis metabolism in BC patients. Our work will be of potential benefit to understanding the pathogenic process of BC and will offer valuable information for noninvasive diagnosis of the disease. Bladder cancer (BC) is one of the most common cancers and has a high mortality rate. However, both metabolite variations and metabolic pathways related to the pathogenic process of BC remain to be addressed, such results might contribute to early detection of the disease. 1H nuclear magnetic resonance (NMR)-based metabolomics was applied to identify differences of serum metabolic profiles among BC, calculi patients and healthy subjects. Serum metabolic profiles of BC patients are distinctly different from those of calculi and healthy subjects. Compared with those from healthy subjects, serum samples from BC patients show decreased levels of isoleucine/leucine, tyrosine, lactate, glycine, citrate, as well as increased levels of lipids and glucose. The results reveal disturbed metabolic pathways of aromatic amino acids, glycolysis and citrate cycle, as well as lipogenesis metabolism in BC patients. Our work will be of potential benefit to understanding the pathogenic process of BC and will offer valuable information for noninvasive diagnosis of the disease. |
| Author | LIN, Donghai CAO, Ming ZHAO, Liangcai XUE, Wei CHEN, Haige |
| Author_xml | – sequence: 1 fullname: CAO, Ming organization: Department of Urologic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University – sequence: 2 fullname: ZHAO, Liangcai organization: Shanghai Institute of Materia Medica, Chinese Academy of Sciences – sequence: 3 fullname: CHEN, Haige organization: Department of Urologic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University – sequence: 4 fullname: XUE, Wei organization: Department of Urologic Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University – sequence: 5 fullname: LIN, Donghai organization: Shanghai Institute of Materia Medica, Chinese Academy of Sciences |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22687923$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kE1P3DAQhq2KqizQK8cqEhcuWfwVxzkuK1oqQStV9GxNnAl4ldjUTg78e7za7QohcfJI8zyvR-8JOfLBIyHnjC45Y-oKPAzJuiXXS1mxT2TBhNQl51IdkQVtGC2VkPSYnKS0oZRxzfkXcsy50nXDxYKoX_d_yhYSdsU9TtCGIYzOFqsc-5JcKkJf3M4j-OJ6gK7DWKzBW4xn5HOfP8av-_eU_P1-87C-Le9-__i5Xt2VVolmKjutrcp39kxWTS17oL1A0dR1qzrWd61STKJuLVPQKJk3vGUoqbUt5LFuxCm53OU-x_BvxjSZ0SWLwwAew5wMo5yyhjIqMnrxDt2EOW7rMUxKrWglqm3gtz01tyN25jm6EeKL-d9IBpY7wMaQUsT-gDBqtpWbfeWGa5Mrz4J8J1g3weSCnyK44WPtaqelnO8fMb459yNjtTM2aYJHPNwFcXJ2wLd4tXcOO_sE0aAXr-rqrDk |
| CitedBy_id | crossref_primary_10_1021_pr500379n crossref_primary_10_1002_ijc_30016 crossref_primary_10_3892_mmr_2019_10609 crossref_primary_10_1155_2020_8839215 crossref_primary_10_1016_j_advms_2022_12_002 crossref_primary_10_1016_j_bios_2014_11_019 crossref_primary_10_1038_s41598_019_47282_6 crossref_primary_10_3390_onco5020013 crossref_primary_10_1038_s41598_022_19576_9 crossref_primary_10_4111_icu_2018_59_2_72 crossref_primary_10_3389_fonc_2021_680910 crossref_primary_10_1186_s40170_023_00324_0 crossref_primary_10_1007_s00216_016_9797_0 crossref_primary_10_1039_c2mb25353d crossref_primary_10_3390_metabo14030173 crossref_primary_10_1021_pr500966h crossref_primary_10_1002_nbm_3927 crossref_primary_10_3390_cancers11070914 crossref_primary_10_1016_j_jpba_2014_08_020 crossref_primary_10_1016_j_trsl_2016_07_018 crossref_primary_10_3389_fonc_2020_00717 crossref_primary_10_1016_j_heliyon_2024_e28949 crossref_primary_10_1007_s40291_013_0023_x crossref_primary_10_1111_lam_12247 crossref_primary_10_3390_ijms23084173 crossref_primary_10_3390_metabo11090591 crossref_primary_10_1016_j_ctrv_2016_03_005 crossref_primary_10_1021_pr4004135 crossref_primary_10_1016_j_jpha_2022_08_004 crossref_primary_10_1021_pr400859w crossref_primary_10_3390_ijms25063347 crossref_primary_10_1080_14737159_2016_1244006 crossref_primary_10_1186_s11658_023_00442_z crossref_primary_10_1016_j_fuel_2020_118920 crossref_primary_10_1016_j_clnu_2024_05_003 crossref_primary_10_3390_cancers11050686 crossref_primary_10_3390_cancers13112719 crossref_primary_10_3233_BLC_160075 crossref_primary_10_1158_1055_9965_EPI_18_0936 crossref_primary_10_1007_s11306_019_1555_9 crossref_primary_10_1021_ac5011684 crossref_primary_10_1016_j_bbcan_2019_188332 crossref_primary_10_1016_j_ajur_2022_11_005 crossref_primary_10_4155_bio_15_192 crossref_primary_10_1080_14789450_2019_1583105 crossref_primary_10_1096_fj_202101993RR crossref_primary_10_3892_or_2017_5954 crossref_primary_10_1002_jat_2874 crossref_primary_10_3748_wjg_v20_i36_12874 crossref_primary_10_1080_10408398_2014_964799 crossref_primary_10_1051_medsci_2013295007 crossref_primary_10_3389_fmolb_2021_727144 crossref_primary_10_3390_molecules26113096 crossref_primary_10_5213_inj_2346250_125 crossref_primary_10_1007_s13277_015_3482_3 crossref_primary_10_1002_mrc_3985 crossref_primary_10_1016_j_bbrc_2015_02_149 crossref_primary_10_1002_jssc_201400638 crossref_primary_10_1007_s00216_023_04730_7 crossref_primary_10_18632_oncotarget_1744 crossref_primary_10_1007_s11306_016_1042_5 crossref_primary_10_1002_cncr_31890 |
| Cites_doi | 10.1093/clinchem/28.5.1215 10.3322/CA.2007.0010 10.1002/path.1398 10.1111/j.1349-7006.2009.01086.x 10.1186/bcr325 10.1002/cncr.22224 10.1021/pr9004162 10.1016/j.urolonc.2008.12.010 10.1021/pr100480r 10.1007/s00428-010-0993-6 10.1007/s00204-010-0609-6 10.1007/BF02781923 10.1080/004982599238047 10.1016/j.aca.2008.06.051 10.1093/jn/136.1.314S 10.1093/ajcn/24.7.841 10.1080/01635589709514610 10.1158/0008-5472.CAN-05-3260 10.1593/neo.81396 10.1152/ajpendo.1983.244.2.E151 10.1586/14737140.7.8.1105 10.1016/S0378-4347(97)00206-5 10.1021/ac00101a004 10.1002/1097-0142(19871001)60:7<1423::AID-CNCR2820600702>3.0.CO;2-6 10.1097/WON.0b013e3181aaf1e7 10.1093/jnci/96.24.1805 10.1007/s11010-005-8841-8 10.1258/0004563053857851 10.1016/j.juro.2008.01.084 10.1371/journal.pmed.1000201 10.1080/00365520600587444 10.1021/ac901028b 10.1186/gm35 10.1016/j.urology.2009.06.047 |
| ContentType | Journal Article |
| Copyright | 2012 by The Japan Society for Analytical Chemistry The Japan Society for Analytical Chemistry 2012 Copyright Japan Science and Technology Agency 2012 |
| Copyright_xml | – notice: 2012 by The Japan Society for Analytical Chemistry – notice: The Japan Society for Analytical Chemistry 2012 – notice: Copyright Japan Science and Technology Agency 2012 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QF 7QO 7QQ 7SE 7SR 7U5 8BQ 8FD FR3 H8G JG9 L7M P64 7X8 |
| DOI | 10.2116/analsci.28.451 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Aluminium Industry Abstracts Biotechnology Research Abstracts Ceramic Abstracts Corrosion Abstracts Engineered Materials Abstracts Solid State and Superconductivity Abstracts METADEX Technology Research Database Engineering Research Database Copper Technical Reference Library Materials Research Database Advanced Technologies Database with Aerospace Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Materials Research Database Aluminium Industry Abstracts Technology Research Database Ceramic Abstracts METADEX Biotechnology and BioEngineering Abstracts Copper Technical Reference Library Engineered Materials Abstracts Biotechnology Research Abstracts Solid State and Superconductivity Abstracts Engineering Research Database Corrosion Abstracts Advanced Technologies Database with Aerospace MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Materials Research Database |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Chemistry |
| EISSN | 1348-2246 |
| EndPage | 456 |
| ExternalDocumentID | 3118250941 22687923 10_2116_analsci_28_451 article_analsci_28_5_28_451_article_char_en |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- 23M 2WC 406 5GY 6J9 7.U AATNV AAYFA ACGFO ACIWK ACPRK ADBBV ADOXG AENEX AESKC AFRAH AIAKS ALMA_UNASSIGNED_HOLDINGS AMXSW AMYLF BAWUL CS3 DIK E3Z EBS EJD F5P GX1 HH5 IWAJR JSF JSH JZLTJ KQ8 LLZTM M~E NPVJJ OK1 P2P RDB RJT RNS RSV RZJ RZV SOJ TN5 TR2 UPT XSB ZMTXR ~02 0R~ 3O- 53G AACDK AAJBT AASML ABAKF ABJNI ABTKH ACAOD ACDTI ACPIV ACZOJ AEFQL AEMSY AFBBN AGMZJ AGQEE AI. AIGIU DPUIP EBLON FIGPU ROL SJYHP TKC VH1 AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION OVT CGR CUY CVF ECM EIF NPM 7QF 7QO 7QQ 7SE 7SR 7U5 8BQ 8FD ABRTQ FR3 H8G JG9 L7M P64 7X8 |
| ID | FETCH-LOGICAL-c639t-d88c6211f145974fa0f3e3977b6d1fdb6614e8bc16a964e392b1e40ccba92b793 |
| ISSN | 0910-6340 1348-2246 |
| IngestDate | Fri Jul 11 01:44:54 EDT 2025 Wed Aug 27 14:43:47 EDT 2025 Wed Feb 19 02:37:11 EST 2025 Thu Apr 24 23:07:57 EDT 2025 Tue Jul 01 01:37:08 EDT 2025 Fri Feb 21 02:42:33 EST 2025 Thu Aug 17 20:29:12 EDT 2023 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 5 |
| Language | English |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c639t-d88c6211f145974fa0f3e3977b6d1fdb6614e8bc16a964e392b1e40ccba92b793 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| OpenAccessLink | https://www.jstage.jst.go.jp/article/analsci/28/5/28_451/_article/-char/en |
| PMID | 22687923 |
| PQID | 1448605359 |
| PQPubID | 1966371 |
| PageCount | 6 |
| ParticipantIDs | proquest_miscellaneous_1020190103 proquest_journals_1448605359 pubmed_primary_22687923 crossref_primary_10_2116_analsci_28_451 crossref_citationtrail_10_2116_analsci_28_451 springer_journals_10_2116_analsci_28_451 jstage_primary_article_analsci_28_5_28_451_article_char_en |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2012-00-00 |
| PublicationDateYYYYMMDD | 2012-01-01 |
| PublicationDate_xml | – year: 2012 text: 2012-00-00 |
| PublicationDecade | 2010 |
| PublicationPlace | Singapore |
| PublicationPlace_xml | – name: Singapore – name: Japan – name: Tokyo |
| PublicationTitle | Analytical Sciences |
| PublicationTitleAbbrev | ANAL. SCI |
| PublicationTitleAlternate | Anal Sci |
| PublicationYear | 2012 |
| Publisher | The Japan Society for Analytical Chemistry Springer Nature Singapore Nature Publishing Group |
| Publisher_xml | – name: The Japan Society for Analytical Chemistry – name: Springer Nature Singapore – name: Nature Publishing Group |
| References | 10. J. Tang, C. Y. Tan, M. Oresic, and A. Vidal-Puig, Genome Med., 2009, 1, 35. 18. T. Kano, M. Nagaki, T. Takahashi, H. Ohnishi, K. Saitoh, K. Kimura, and Y. Muto, Gastroenterol. Jpn., 1991, 26, 344. 3. R. A. Badalament, D. K. Hermansen, M. Kimmel, H. Gay, H. W. Herr, W. R. Fair, W. F. Whitmore, Jr., and M. R. Melamed, Cancer, 1987, 60, 1423. 29. S. Tiziani, V. Lopes, and U. L. Gunther, Neoplasia, 2009, 11, 269. 11. H. J. Issaq, O. Nativ, T. Waybright, B. Luke, T. D. Veenstra, E. J. Issaq, A. Kravstov, and M. Mullerad, J. Urol., 2008, 179, 2422. 16. L. C. Costello and R. B. Franklin, Mol. Cell. Biochem., 2005, 280, 1. 2. E. M. Messing, R. Madeb, T. Young, K. W. Gilchrist, L. Bram, E. B. Greenberg, J. D. Wegenke, L. Stephenson, J. Gee, and C. Feng, Cancer, 2006, 107, 2173. 8. M. Mamas, W. B. Dunn, L. Neyses, and R. Goodacre, Arch. Toxicol., 2011, 85, 5. 20. Y. M. Fu, Z. X. Yu, V. J. Ferrans, and G. G. Meadows, Nutr. Cancer, 1997, 29, 104. 34. A. L. Dill, D. R. Ifa, N. E. Manicke, A. B. Costa, J. A. Ramos-Vara, D. W. Knapp, and R. G. Cooks, Anal. Chem., 2009, 81, 8758. 30. K. Garber, J. Natl. Cancer Inst., 2004, 96, 1805. 26. A. Ehrmann-Josko, J. Sieminska, B. Gornicka, B. Ziarkiewicz-Wroblewska, B. Ziolkowski, and J. Muszynski, Scand. J. Gastroenterol., 2006, 41, 1079. 13. J. K. Nicholson, P. J. Foxall, M. Spraul, R. D. Farrant, and J. C. Lindon, Anal. Chem., 1995, 67, 793. 15. A. R. Patel and S. C. Campbell, J. Wound Ostomy Continence Nurs., 2009, 36, 413. 22. D. F. Davidson, Ann. Clin. Biochem., 2005, 42, 200. 28. C. S. Yeh, J. Y. Wang, F. Y. Chung, S. C. Lee, M. Y. Huang, C. W. Kuo, M. J. Yang, and S. R. Lin, Oncol. Rep., 2008, 19, 81. 24. J. T. Brosnan, K. C. Man, D. E. Hall, S. A. Colbourne, and M. E. Brosnan, Am. J. Physiol., 1983, 244, E151. 1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray, and M. J. Thun, CA Cancer J. Clin., 2008, 58, 71. 12. A. R. Patel, E. S. Chan, D. E. Hansel, C. T. Powell, W. D. Heston, and W. A. Larchian, Urology, 2009, 75, 799. 33. O. De Wever and M. Mareel, J. Pathol., 2003, 200, 429. 27. T. Stocks, K. Rapp, T. Bjorge, J. Manjer, H. Ulmer, R. Selmer, A. Lukanova, D. Johansen, H. Concin, S. Tretli, G. Hallmans, H. Jonsson, and P. Stattin, PLoS Med., 2009, 6, e1000201. 35. N. Badjatia, A. Satyam, P. Singh, A. Seth, and A. Sharma, Urol. Oncol., 2010, 28, 360. 6. H. Gao, B. Dong, X. Liu, H. Xuan, Y. Huang, and D. Lin, Anal. Chim. Acta, 2008, 624, 269. 17. M. A. Hilton, Clin. Chem., 1982, 28, 1215. 25. H. A. Choudry, M. Pan, A. M. Karinch, and W. W. Souba, J. Nutr., 2006, 136, 314S. 19. G. T. Bryan, Am. J. Clin. Nutr., 1971, 24, 841. 7. Y. Qiu, G. Cai, M. Su, T. Chen, X. Zheng, Y. Xu, Y. Ni, A. Zhao, L. X. Xu, S. Cai, and W. Jia, J. Proteome Res., 2009, 8, 4844. 32. S. L. Schor and A. M. Schor, Breast Cancer Res., 2001, 3, 373. 9. J. K. Nicholson, J. C. Lindon, and E. Holmes, Xenobiotica, 1999, 29, 1181. 21. S. Letellier, J. P. Garnier, J. Spy, and B. Bousquet, J. Chromatogr., B: Biomed. Sci. Appl., 1997, 696, 9. 14. Z. Zhang, Y. Qiu, Y. Hua, Y. Wang, T. Chen, A. Zhao, Y. Chi, L. Pan, S. Hu, J. Li, C. Yang, G. Li, W. Sun, Z. Cai, and W. Jia, J. Proteome Res., 2010, 9, 4861. 23. I. F. Duarte, C. M. Rocha, A. S. Barros, A. M. Gil, B. J. Goodfellow, I. M. Carreira, J. Bernardo, A. Gomes, V. Sousa, and L. Carvalho, Virchows Arch., 2010, 457, 715. 31. M. I. Koukourakis, A. Giatromanolaki, A. L. Harris, and E. Sivridis, Cancer Res., 2006, 66, 632. 4. T. Lam and G. Nabi, Expert Rev. Anticancer Ther., 2007, 7, 1105. 5. H. Gao, Q. Lu, X. Liu, H. Cong, L. Zhao, H. Wang, and D. Lin, Cancer Sci., 2009, 100, 782. LamTNabiGExpert Rev. Anticancer Ther.2007711051:CAS:528:DC%2BD2sXptFynt70%3D10.1586/14737140.7.8.110518028019 PatelA RChanE SHanselD EPowellC THestonW DLarchianW AUrology20097579910.1016/j.urology.2009.06.04719773032 KanoTNagakiMTakahashiTOhnishiHSaitohKKimuraKMutoYGastroenterol. Jpn.1991263441:STN:280:DyaK3MzmsFWmtg%3D%3D10.1007/BF027819231889691 QiuYCaiGSuMChenTZhengXXuYNiYZhaoAXuL XCaiSJiaWJ. Proteome Res.2009848441:CAS:528:DC%2BD1MXhtV2murrM10.1021/pr900416219678709 NicholsonJ KFoxallP JSpraulMFarrantR DLindonJ CAnal. Chem.1995677931:CAS:528:DyaK2MXjsFajurs%3D10.1021/ac00101a0047762816 TizianiSLopesVGuntherU LNeoplasia2009112691:CAS:528:DC%2BD1MXislOqtrc%3D10.1593/neo.81396192426082647729 MessingE MMadebRYoungTGilchristK WBramLGreenbergE BWegenkeJ DStephensonLGeeJFengCCancer2006107217310.1002/cncr.2222417029275 BryanG TAm. J. Clin. Nutr.1971248411:CAS:528:DyaE3MXks1Wisrw%3D10.1093/ajcn/24.7.8414934541 T. Stocks, K. Rapp, T. Bjorge, J. Manjer, H. Ulmer, R. Selmer, A. Lukanova, D. Johansen, H. Concin, S. Tretli, G. Hallmans, H. Jonsson, and P. Stattin, PLoS Med., 2009, 6, e1000201. DavidsonD FAnn. Clin. Biochem.2005422001:CAS:528:DC%2BD2MXltlOgurs%3D10.1258/000456305385785115949155 H. A. Choudry, M. Pan, A. M. Karinch, and W. W. Souba, J. Nutr., 2006, 136, 314S. MamasMDunnW BNeysesLGoodacreRArch. Toxicol.20118551:CAS:528:DC%2BC3cXhtlSjur7I10.1007/s00204-010-0609-620953584 CostelloL CFranklinR BMol. Cell. Biochem.200528011:CAS:528:DC%2BD2MXht1GlsbrO10.1007/s11010-005-8841-8165119514461431 DuarteI FRochaC MBarrosA SGilA MGoodfellowB JCarreiraI MBernardoJGomesASousaVCarvalhoLVirchows Arch.20104577151:CAS:528:DC%2BC3cXhsVCjsbjN10.1007/s00428-010-0993-620941505 GarberKJ. Natl. Cancer Inst.200496180510.1093/jnci/96.24.180515601632 ZhangZQiuYHuaYWangYChenTZhaoAChiYPanLHuSLiJYangCLiGSunWCaiZJiaWJ. Proteome Res.2010948611:CAS:528:DC%2BC3cXpvVSgsL8%3D10.1021/pr100480r20690664 De WeverOMareelMJ. Pathol.200320042910.1002/path.139812845611 GaoHLuQLiuXCongHZhaoLWangHLinDCancer Sci.20091007821:CAS:528:DC%2BD1MXlsFSrtro%3D10.1111/j.1349-7006.2009.01086.x19469021 J. T. Brosnan, K. C. Man, D. E. Hall, S. A. Colbourne, and M. E. Brosnan, Am. J. Physiol., 1983, 244, E151. BadalamentR AHermansenD KKimmelMGayHHerrH WFairW RWhitmoreW FJr.MelamedM RCancer19876014231:STN:280:DyaL2szgtFaltg%3D%3D10.1002/1097-0142(19871001)60:7<1423::AID-CNCR2820600702>3.0.CO;2-63304614 DillA LIfaD RManickeN ECostaA BRamos-VaraJ AW KnappDCooksR GAnal. Chem.20098187581:CAS:528:DC%2BD1MXht1eltrnP10.1021/ac901028b198107102783352 BadjatiaNSatyamASinghPSethASharmaAUrol. Oncol.2010283601:CAS:528:DC%2BC3cXotVWks7o%3D10.1016/j.urolonc.2008.12.01019171490 NicholsonJ KLindonJ CHolmesEXenobiotica19992911811:CAS:528:DyaK1MXns12ms7k%3D10.1080/00498259923804710598751 SchorS LSchorA MBreast Cancer Res.200133731:CAS:528:DC%2BD38Xjs1alug%3D%3D10.1186/bcr32511737888138703 IssaqH JNativOWaybrightTLukeBVeenstraT DIssaqE JKravstovAMulleradMJ. Urol.200817924221:CAS:528:DC%2BD1cXntlSmt7s%3D10.1016/j.juro.2008.01.08418433783 FuY MYuZ XFerransV JMeadowsG GNutr. Cancer1997291041:CAS:528:DyaK1cXht1GltA%3D%3D10.1080/016355897095146109427972 GaoHDongBLiuXXuanHHuangYLinDAnal. Chim. Acta20086242691:CAS:528:DC%2BD1cXhtVWksr%2FI10.1016/j.aca.2008.06.05118706333 Ehrmann-JoskoASieminskaJGornickaBZiarkiewicz-WroblewskaBZiolkowskiBMuszynskiJScand. J. Gastroenterol.20064110791:CAS:528:DC%2BD28XhtFyks73I10.1080/0036552060058744416938722 PatelA RCampbellS CJ. Wound Ostomy Continence Nurs.20093641310.1097/WON.0b013e3181aaf1e719609162 YehC SWangJ YChungF YLeeS CY HuangMW KuoCYangM JLinS ROncol. Rep.200819811:CAS:528:DC%2BD1cXhtFKru70%3D18097579 KoukourakisM IGiatromanolakiAHarrisA LSivridisECancer Res.2006666321:CAS:528:DC%2BD28XlsFOmuw%3D%3D10.1158/0008-5472.CAN-05-326016423989 JemalASiegelRWardEHaoYXuJMurrayTThunM JCA Cancer J. Clin.2008587110.3322/CA.2007.001018287387 TangJY TanCOresicMVidal-PuigAGenome Med.200913510.1186/gm35193415062664946 S. Letellier, J. P. Garnier, J. Spy, and B. Bousquet, J. Chromatogr, B: Biomed. Sci. Appl., 1997, 696, 9. HiltonM AClin. Chem.19822812151:CAS:528:DyaL38XktVejtLg%3D10.1093/clinchem/28.5.12157074908 E M Messing (2805004_CR2) 2006; 107 S L Schor (2805004_CR32) 2001; 3 2805004_CR24 H Gao (2805004_CR6) 2008; 624 2805004_CR21 C S Yeh (2805004_CR28) 2008; 19 2805004_CR27 S Tiziani (2805004_CR29) 2009; 11 Y M Fu (2805004_CR20) 1997; 29 2805004_CR25 A Ehrmann-Josko (2805004_CR26) 2006; 41 M I Koukourakis (2805004_CR31) 2006; 66 A R Patel (2805004_CR15) 2009; 36 O De Wever (2805004_CR33) 2003; 200 H Gao (2805004_CR5) 2009; 100 M A Hilton (2805004_CR17) 1982; 28 H J Issaq (2805004_CR11) 2008; 179 K Garber (2805004_CR30) 2004; 96 J Tang (2805004_CR10) 2009; 1 L C Costello (2805004_CR16) 2005; 280 D F Davidson (2805004_CR22) 2005; 42 Z Zhang (2805004_CR14) 2010; 9 G T Bryan (2805004_CR19) 1971; 24 A R Patel (2805004_CR12) 2009; 75 Y Qiu (2805004_CR7) 2009; 8 R A Badalament (2805004_CR3) 1987; 60 J K Nicholson (2805004_CR13) 1995; 67 J K Nicholson (2805004_CR9) 1999; 29 T Kano (2805004_CR18) 1991; 26 A L Dill (2805004_CR34) 2009; 81 A Jemal (2805004_CR1) 2008; 58 M Mamas (2805004_CR8) 2011; 85 T Lam (2805004_CR4) 2007; 7 N Badjatia (2805004_CR35) 2010; 28 I F Duarte (2805004_CR23) 2010; 457 |
| References_xml | – reference: 14. Z. Zhang, Y. Qiu, Y. Hua, Y. Wang, T. Chen, A. Zhao, Y. Chi, L. Pan, S. Hu, J. Li, C. Yang, G. Li, W. Sun, Z. Cai, and W. Jia, J. Proteome Res., 2010, 9, 4861. – reference: 33. O. De Wever and M. Mareel, J. Pathol., 2003, 200, 429. – reference: 1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray, and M. J. Thun, CA Cancer J. Clin., 2008, 58, 71. – reference: 28. C. S. Yeh, J. Y. Wang, F. Y. Chung, S. C. Lee, M. Y. Huang, C. W. Kuo, M. J. Yang, and S. R. Lin, Oncol. Rep., 2008, 19, 81. – reference: 3. R. A. Badalament, D. K. Hermansen, M. Kimmel, H. Gay, H. W. Herr, W. R. Fair, W. F. Whitmore, Jr., and M. R. Melamed, Cancer, 1987, 60, 1423. – reference: 19. G. T. Bryan, Am. J. Clin. Nutr., 1971, 24, 841. – reference: 11. H. J. Issaq, O. Nativ, T. Waybright, B. Luke, T. D. Veenstra, E. J. Issaq, A. Kravstov, and M. Mullerad, J. Urol., 2008, 179, 2422. – reference: 10. J. Tang, C. Y. Tan, M. Oresic, and A. Vidal-Puig, Genome Med., 2009, 1, 35. – reference: 18. T. Kano, M. Nagaki, T. Takahashi, H. Ohnishi, K. Saitoh, K. Kimura, and Y. Muto, Gastroenterol. Jpn., 1991, 26, 344. – reference: 16. L. C. Costello and R. B. Franklin, Mol. Cell. Biochem., 2005, 280, 1. – reference: 15. A. R. Patel and S. C. Campbell, J. Wound Ostomy Continence Nurs., 2009, 36, 413. – reference: 22. D. F. Davidson, Ann. Clin. Biochem., 2005, 42, 200. – reference: 24. J. T. Brosnan, K. C. Man, D. E. Hall, S. A. Colbourne, and M. E. Brosnan, Am. J. Physiol., 1983, 244, E151. – reference: 27. T. Stocks, K. Rapp, T. Bjorge, J. Manjer, H. Ulmer, R. Selmer, A. Lukanova, D. Johansen, H. Concin, S. Tretli, G. Hallmans, H. Jonsson, and P. Stattin, PLoS Med., 2009, 6, e1000201. – reference: 9. J. K. Nicholson, J. C. Lindon, and E. Holmes, Xenobiotica, 1999, 29, 1181. – reference: 34. A. L. Dill, D. R. Ifa, N. E. Manicke, A. B. Costa, J. A. Ramos-Vara, D. W. Knapp, and R. G. Cooks, Anal. Chem., 2009, 81, 8758. – reference: 4. T. Lam and G. Nabi, Expert Rev. Anticancer Ther., 2007, 7, 1105. – reference: 29. S. Tiziani, V. Lopes, and U. L. Gunther, Neoplasia, 2009, 11, 269. – reference: 23. I. F. Duarte, C. M. Rocha, A. S. Barros, A. M. Gil, B. J. Goodfellow, I. M. Carreira, J. Bernardo, A. Gomes, V. Sousa, and L. Carvalho, Virchows Arch., 2010, 457, 715. – reference: 2. E. M. Messing, R. Madeb, T. Young, K. W. Gilchrist, L. Bram, E. B. Greenberg, J. D. Wegenke, L. Stephenson, J. Gee, and C. Feng, Cancer, 2006, 107, 2173. – reference: 8. M. Mamas, W. B. Dunn, L. Neyses, and R. Goodacre, Arch. Toxicol., 2011, 85, 5. – reference: 12. A. R. Patel, E. S. Chan, D. E. Hansel, C. T. Powell, W. D. Heston, and W. A. Larchian, Urology, 2009, 75, 799. – reference: 5. H. Gao, Q. Lu, X. Liu, H. Cong, L. Zhao, H. Wang, and D. Lin, Cancer Sci., 2009, 100, 782. – reference: 25. H. A. Choudry, M. Pan, A. M. Karinch, and W. W. Souba, J. Nutr., 2006, 136, 314S. – reference: 32. S. L. Schor and A. M. Schor, Breast Cancer Res., 2001, 3, 373. – reference: 35. N. Badjatia, A. Satyam, P. Singh, A. Seth, and A. Sharma, Urol. Oncol., 2010, 28, 360. – reference: 26. A. Ehrmann-Josko, J. Sieminska, B. Gornicka, B. Ziarkiewicz-Wroblewska, B. Ziolkowski, and J. Muszynski, Scand. J. Gastroenterol., 2006, 41, 1079. – reference: 30. K. Garber, J. Natl. Cancer Inst., 2004, 96, 1805. – reference: 13. J. K. Nicholson, P. J. Foxall, M. Spraul, R. D. Farrant, and J. C. Lindon, Anal. Chem., 1995, 67, 793. – reference: 21. S. Letellier, J. P. Garnier, J. Spy, and B. Bousquet, J. Chromatogr., B: Biomed. Sci. Appl., 1997, 696, 9. – reference: 31. M. I. Koukourakis, A. Giatromanolaki, A. L. Harris, and E. Sivridis, Cancer Res., 2006, 66, 632. – reference: 17. M. A. Hilton, Clin. Chem., 1982, 28, 1215. – reference: 6. H. Gao, B. Dong, X. Liu, H. Xuan, Y. Huang, and D. Lin, Anal. Chim. Acta, 2008, 624, 269. – reference: 7. Y. Qiu, G. Cai, M. Su, T. Chen, X. Zheng, Y. Xu, Y. Ni, A. Zhao, L. X. Xu, S. Cai, and W. Jia, J. Proteome Res., 2009, 8, 4844. – reference: 20. Y. M. Fu, Z. X. Yu, V. J. Ferrans, and G. G. Meadows, Nutr. Cancer, 1997, 29, 104. – reference: J. T. Brosnan, K. C. Man, D. E. Hall, S. A. Colbourne, and M. E. Brosnan, Am. J. Physiol., 1983, 244, E151. – reference: MessingE MMadebRYoungTGilchristK WBramLGreenbergE BWegenkeJ DStephensonLGeeJFengCCancer2006107217310.1002/cncr.2222417029275 – reference: HiltonM AClin. Chem.19822812151:CAS:528:DyaL38XktVejtLg%3D10.1093/clinchem/28.5.12157074908 – reference: BadjatiaNSatyamASinghPSethASharmaAUrol. Oncol.2010283601:CAS:528:DC%2BC3cXotVWks7o%3D10.1016/j.urolonc.2008.12.01019171490 – reference: IssaqH JNativOWaybrightTLukeBVeenstraT DIssaqE JKravstovAMulleradMJ. Urol.200817924221:CAS:528:DC%2BD1cXntlSmt7s%3D10.1016/j.juro.2008.01.08418433783 – reference: S. Letellier, J. P. Garnier, J. Spy, and B. Bousquet, J. Chromatogr, B: Biomed. Sci. Appl., 1997, 696, 9. – reference: BryanG TAm. J. Clin. Nutr.1971248411:CAS:528:DyaE3MXks1Wisrw%3D10.1093/ajcn/24.7.8414934541 – reference: GaoHDongBLiuXXuanHHuangYLinDAnal. Chim. Acta20086242691:CAS:528:DC%2BD1cXhtVWksr%2FI10.1016/j.aca.2008.06.05118706333 – reference: GaoHLuQLiuXCongHZhaoLWangHLinDCancer Sci.20091007821:CAS:528:DC%2BD1MXlsFSrtro%3D10.1111/j.1349-7006.2009.01086.x19469021 – reference: PatelA RChanE SHanselD EPowellC THestonW DLarchianW AUrology20097579910.1016/j.urology.2009.06.04719773032 – reference: NicholsonJ KFoxallP JSpraulMFarrantR DLindonJ CAnal. Chem.1995677931:CAS:528:DyaK2MXjsFajurs%3D10.1021/ac00101a0047762816 – reference: JemalASiegelRWardEHaoYXuJMurrayTThunM JCA Cancer J. Clin.2008587110.3322/CA.2007.001018287387 – reference: LamTNabiGExpert Rev. Anticancer Ther.2007711051:CAS:528:DC%2BD2sXptFynt70%3D10.1586/14737140.7.8.110518028019 – reference: T. Stocks, K. Rapp, T. Bjorge, J. Manjer, H. Ulmer, R. Selmer, A. Lukanova, D. Johansen, H. Concin, S. Tretli, G. Hallmans, H. Jonsson, and P. Stattin, PLoS Med., 2009, 6, e1000201. – reference: PatelA RCampbellS CJ. Wound Ostomy Continence Nurs.20093641310.1097/WON.0b013e3181aaf1e719609162 – reference: YehC SWangJ YChungF YLeeS CY HuangMW KuoCYangM JLinS ROncol. Rep.200819811:CAS:528:DC%2BD1cXhtFKru70%3D18097579 – reference: FuY MYuZ XFerransV JMeadowsG GNutr. Cancer1997291041:CAS:528:DyaK1cXht1GltA%3D%3D10.1080/016355897095146109427972 – reference: TizianiSLopesVGuntherU LNeoplasia2009112691:CAS:528:DC%2BD1MXislOqtrc%3D10.1593/neo.81396192426082647729 – reference: KanoTNagakiMTakahashiTOhnishiHSaitohKKimuraKMutoYGastroenterol. Jpn.1991263441:STN:280:DyaK3MzmsFWmtg%3D%3D10.1007/BF027819231889691 – reference: CostelloL CFranklinR BMol. Cell. Biochem.200528011:CAS:528:DC%2BD2MXht1GlsbrO10.1007/s11010-005-8841-8165119514461431 – reference: DillA LIfaD RManickeN ECostaA BRamos-VaraJ AW KnappDCooksR GAnal. Chem.20098187581:CAS:528:DC%2BD1MXht1eltrnP10.1021/ac901028b198107102783352 – reference: DuarteI FRochaC MBarrosA SGilA MGoodfellowB JCarreiraI MBernardoJGomesASousaVCarvalhoLVirchows Arch.20104577151:CAS:528:DC%2BC3cXhsVCjsbjN10.1007/s00428-010-0993-620941505 – reference: GarberKJ. Natl. Cancer Inst.200496180510.1093/jnci/96.24.180515601632 – reference: SchorS LSchorA MBreast Cancer Res.200133731:CAS:528:DC%2BD38Xjs1alug%3D%3D10.1186/bcr32511737888138703 – reference: TangJY TanCOresicMVidal-PuigAGenome Med.200913510.1186/gm35193415062664946 – reference: QiuYCaiGSuMChenTZhengXXuYNiYZhaoAXuL XCaiSJiaWJ. Proteome Res.2009848441:CAS:528:DC%2BD1MXhtV2murrM10.1021/pr900416219678709 – reference: NicholsonJ KLindonJ CHolmesEXenobiotica19992911811:CAS:528:DyaK1MXns12ms7k%3D10.1080/00498259923804710598751 – reference: H. A. Choudry, M. Pan, A. M. Karinch, and W. W. Souba, J. Nutr., 2006, 136, 314S. – reference: KoukourakisM IGiatromanolakiAHarrisA LSivridisECancer Res.2006666321:CAS:528:DC%2BD28XlsFOmuw%3D%3D10.1158/0008-5472.CAN-05-326016423989 – reference: MamasMDunnW BNeysesLGoodacreRArch. Toxicol.20118551:CAS:528:DC%2BC3cXhtlSjur7I10.1007/s00204-010-0609-620953584 – reference: BadalamentR AHermansenD KKimmelMGayHHerrH WFairW RWhitmoreW FJr.MelamedM RCancer19876014231:STN:280:DyaL2szgtFaltg%3D%3D10.1002/1097-0142(19871001)60:7<1423::AID-CNCR2820600702>3.0.CO;2-63304614 – reference: Ehrmann-JoskoASieminskaJGornickaBZiarkiewicz-WroblewskaBZiolkowskiBMuszynskiJScand. J. Gastroenterol.20064110791:CAS:528:DC%2BD28XhtFyks73I10.1080/0036552060058744416938722 – reference: ZhangZQiuYHuaYWangYChenTZhaoAChiYPanLHuSLiJYangCLiGSunWCaiZJiaWJ. Proteome Res.2010948611:CAS:528:DC%2BC3cXpvVSgsL8%3D10.1021/pr100480r20690664 – reference: DavidsonD FAnn. Clin. Biochem.2005422001:CAS:528:DC%2BD2MXltlOgurs%3D10.1258/000456305385785115949155 – reference: De WeverOMareelMJ. Pathol.200320042910.1002/path.139812845611 – volume: 28 start-page: 1215 year: 1982 ident: 2805004_CR17 publication-title: Clin. Chem. doi: 10.1093/clinchem/28.5.1215 – volume: 58 start-page: 71 year: 2008 ident: 2805004_CR1 publication-title: CA Cancer J. Clin. doi: 10.3322/CA.2007.0010 – volume: 200 start-page: 429 year: 2003 ident: 2805004_CR33 publication-title: J. Pathol. doi: 10.1002/path.1398 – volume: 100 start-page: 782 year: 2009 ident: 2805004_CR5 publication-title: Cancer Sci. doi: 10.1111/j.1349-7006.2009.01086.x – volume: 3 start-page: 373 year: 2001 ident: 2805004_CR32 publication-title: Breast Cancer Res. doi: 10.1186/bcr325 – volume: 107 start-page: 2173 year: 2006 ident: 2805004_CR2 publication-title: Cancer doi: 10.1002/cncr.22224 – volume: 8 start-page: 4844 year: 2009 ident: 2805004_CR7 publication-title: J. Proteome Res. doi: 10.1021/pr9004162 – volume: 28 start-page: 360 year: 2010 ident: 2805004_CR35 publication-title: Urol. Oncol. doi: 10.1016/j.urolonc.2008.12.010 – volume: 9 start-page: 4861 year: 2010 ident: 2805004_CR14 publication-title: J. Proteome Res. doi: 10.1021/pr100480r – volume: 457 start-page: 715 year: 2010 ident: 2805004_CR23 publication-title: Virchows Arch. doi: 10.1007/s00428-010-0993-6 – volume: 85 start-page: 5 year: 2011 ident: 2805004_CR8 publication-title: Arch. Toxicol. doi: 10.1007/s00204-010-0609-6 – volume: 26 start-page: 344 year: 1991 ident: 2805004_CR18 publication-title: Gastroenterol. Jpn. doi: 10.1007/BF02781923 – volume: 19 start-page: 81 year: 2008 ident: 2805004_CR28 publication-title: Oncol. Rep. – volume: 29 start-page: 1181 year: 1999 ident: 2805004_CR9 publication-title: Xenobiotica doi: 10.1080/004982599238047 – volume: 624 start-page: 269 year: 2008 ident: 2805004_CR6 publication-title: Anal. Chim. Acta doi: 10.1016/j.aca.2008.06.051 – ident: 2805004_CR25 doi: 10.1093/jn/136.1.314S – volume: 24 start-page: 841 year: 1971 ident: 2805004_CR19 publication-title: Am. J. Clin. Nutr. doi: 10.1093/ajcn/24.7.841 – volume: 29 start-page: 104 year: 1997 ident: 2805004_CR20 publication-title: Nutr. Cancer doi: 10.1080/01635589709514610 – volume: 66 start-page: 632 year: 2006 ident: 2805004_CR31 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-05-3260 – volume: 11 start-page: 269 year: 2009 ident: 2805004_CR29 publication-title: Neoplasia doi: 10.1593/neo.81396 – ident: 2805004_CR24 doi: 10.1152/ajpendo.1983.244.2.E151 – volume: 7 start-page: 1105 year: 2007 ident: 2805004_CR4 publication-title: Expert Rev. Anticancer Ther. doi: 10.1586/14737140.7.8.1105 – ident: 2805004_CR21 doi: 10.1016/S0378-4347(97)00206-5 – volume: 67 start-page: 793 year: 1995 ident: 2805004_CR13 publication-title: Anal. Chem. doi: 10.1021/ac00101a004 – volume: 60 start-page: 1423 year: 1987 ident: 2805004_CR3 publication-title: Cancer doi: 10.1002/1097-0142(19871001)60:7<1423::AID-CNCR2820600702>3.0.CO;2-6 – volume: 36 start-page: 413 year: 2009 ident: 2805004_CR15 publication-title: J. Wound Ostomy Continence Nurs. doi: 10.1097/WON.0b013e3181aaf1e7 – volume: 96 start-page: 1805 year: 2004 ident: 2805004_CR30 publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/96.24.1805 – volume: 280 start-page: 1 year: 2005 ident: 2805004_CR16 publication-title: Mol. Cell. Biochem. doi: 10.1007/s11010-005-8841-8 – volume: 42 start-page: 200 year: 2005 ident: 2805004_CR22 publication-title: Ann. Clin. Biochem. doi: 10.1258/0004563053857851 – volume: 179 start-page: 2422 year: 2008 ident: 2805004_CR11 publication-title: J. Urol. doi: 10.1016/j.juro.2008.01.084 – ident: 2805004_CR27 doi: 10.1371/journal.pmed.1000201 – volume: 41 start-page: 1079 year: 2006 ident: 2805004_CR26 publication-title: Scand. J. Gastroenterol. doi: 10.1080/00365520600587444 – volume: 81 start-page: 8758 year: 2009 ident: 2805004_CR34 publication-title: Anal. Chem. doi: 10.1021/ac901028b – volume: 1 start-page: 35 year: 2009 ident: 2805004_CR10 publication-title: Genome Med. doi: 10.1186/gm35 – volume: 75 start-page: 799 year: 2009 ident: 2805004_CR12 publication-title: Urology doi: 10.1016/j.urology.2009.06.047 |
| SSID | ssj0012822 |
| Score | 2.2564979 |
| Snippet | Bladder cancer (BC) is one of the most common cancers and has a high mortality rate. However, both metabolite variations and metabolic pathways related to the... |
| SourceID | proquest pubmed crossref springer jstage |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 451 |
| SubjectTerms | Amino acids Analytical Chemistry Bladder cancer Chemistry Humans Lipids Metabolites Metabolome Metabolomics NMR Nuclear magnetic resonance Nuclear Magnetic Resonance, Biomolecular Urinary Bladder Neoplasms - blood Urinary Bladder Neoplasms - diagnosis Urinary Bladder Neoplasms - metabolism |
| Title | NMR-based Metabolomic Analysis of Human Bladder Cancer |
| URI | https://www.jstage.jst.go.jp/article/analsci/28/5/28_451/_article/-char/en https://link.springer.com/article/10.2116/analsci.28.451 https://www.ncbi.nlm.nih.gov/pubmed/22687923 https://www.proquest.com/docview/1448605359 https://www.proquest.com/docview/1020190103 |
| Volume | 28 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| ispartofPNX | Analytical Sciences, 2012/05/10, Vol.28(5), pp.451-456 |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3di9QwEA96CvoiflvvTioICtK9Nk276b3JcseidyvKLu5byVeXlaWVs_viX-9Mk37sucLpSynJkLbzS9KZyXwQ8mZsIlmwQgSUpSxgqZGByBQNjKaxLnjExBgDnC9n6XTBPi6TZV8vr4kuqeVI_dobV_I_qEIb4IpRsv-AbDcoNMA94AtXQBiuN8J4dvk1wN-QxkLQgOYGQ4zfi0GeEVuCT25wf7lCDy_lvHG7_MlAW_ehkap3KZyIyvrVu3-btS5XVpEX5UqJde8bYDevqVivuomy3Da20m9mPbQsRAMzYxQz4DR1xkGzp83tnZQP5kgy2AiZTSN7fYMGddNmJgYE1HpE-cgR7mbCnn3OzxcXF_n8bDm_Te5QUAGwOsWnL_0JEbq_Nsq0eyubkBPHP9kdfUfguPsdZO6V2adO_HEU3kgY84fkgVMN_A8W50fklikfk3uTtiLfE5J2ePsDvP0Wb78q_AZv3-HtW7yfksX52XwyDVzdi0CBvFgHmnOVwpcUEUN1rxBhERsU1GWqo0JLFKkMlypKRZYy6KEyMixUSgq4hQ33GTkoq9K8IL6OeaK51OMwE0xQkO24wIPxzHChQ516JGiZkyuXFB5rk2xyUA6RmbljZk55Dsz0yNuO_odNh_JXylPL647OLZMhXeKIuz4MNYSV7ZGjFp_crbefoKRiwbQkTjKPvO66AQI84hKlqbZAA9oPirhh7JHnFtfu-aBocMyW6ZF3LdCDwfd-xMsbPOiQ3MfFY81yR-SgvtqaYxBUa_mqmbG_AQKglTM |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=NMR-based+metabolomic+analysis+of+human+bladder+cancer&rft.jtitle=Analytical+sciences&rft.au=Cao%2C+Ming&rft.au=Zhao%2C+Liangcai&rft.au=Chen%2C+Haige&rft.au=Xue%2C+Wei&rft.date=2012&rft.issn=1348-2246&rft.eissn=1348-2246&rft.volume=28&rft.issue=5&rft.spage=451&rft_id=info:doi/10.2116%2Fanalsci.28.451&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0910-6340&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0910-6340&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0910-6340&client=summon |